OPPOSITE EFFECTS OF AN AGONIST, RO5-4864, AND AN ANTAGONIST, PK-11195, OF THE PERIPHERAL TYPE BENZODIAZEPINE BINDING-SITES ON AUDIOGENIC-SEIZURES IN DBA/2J MICE

Two compounds with high affinity for the peripheral type benzodiazepine binding sites, PK 11195 (an isoquinoline derivative) and RO5-4864 (a benzodiazepine derivative) can modify the sensitivity of DBA/2J mice to audiogenic seizures. RO5-4864 (1-15 mg/kg) facilitates in a dose-dependent manner the audiogenic seizures and PK 11195 (2-5 mg/kg) antagonizes the RO5-4864 effects. At these doses PK 11195 alone does not modify the sensitivity to audiogenic seizures but at doses between 20 and 80 mg/kg it protects DBA/2J mice against audiogenic seizures. PK 11195 is inactive against the facilitation of audiogenic seizures by ethyl-.beta.-carboline-3-carboxylate (a brain benzodiazepine receptor inverse agonist) and against the seizure elicited in absence of noise stimuli by RO5-4864 at doses between 20 and 40 mg/kg. Evidently, facilitation by RO5-4864 of the audiogenic seizures and its antagonism by PK 11195 are mediated by the peripheral type benzodiazepine binding sites. Results agree with the thermodynamic analysis of the binding data which suggested that RO5-4864 might be an agonist and PK 11195 an antagonist. The good correlation between pharmacological effects and the occupancy degree of the binding sites as measured by the displacement of the in vivo [3H]-PK 11195 binding give an additional support to binding sites mediated effects.